All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Cervical Intraepithelial Neoplasia-12189229
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 12189229 D76E
E7
E7
Cervical Intraepithelial Neoplasia
G
R
S
L
View
2 12189229 R9K
E7
E7
Cervical Intraepithelial Neoplasia
G
R
S
L
View
3 12189229 T74A
E7
E7
Cervical Intraepithelial Neoplasia
G
R
S
L
View
4 12189229 D86E
E6
E6
Cervical Intraepithelial Neoplasia
G
R
S
L
View
5 12189229 K93N
E6
E6
Cervical Intraepithelial Neoplasia
G
R
S
L
View
6 12189229 C632T
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
R
S
L
View
7 12189229 G41R
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
R
S
L
View
8 12189229 G63D
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
R
S
L
View
9 12189229 G63S
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
R
S
L
View
10 12189229 G760A
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
R
S
L
View
11 12189229 T20I
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
R
S
L
View
12 12189229 V77A
E7
E7
Uterine Cervical Neoplasms
Cervical Intraepithelial Neoplasia
G
R
S
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.